Insider Trades83 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 214,500 | $43.27 | $2.8B | -19.50% | +49.19% | $9.3M | +0.00% | 10b5-1 | Stalk |
| Mar 13, 2026 | Sell | SUPN | Jack A. Khattar | President, CEO | 35,000 | $50.37 | $2.8B | -19.50% | +49.19% | $1.8M | -1.20% | 10b5-1 | Stalk |
| Mar 6, 2026 | Sell | SUPN | Timothy C Dec | Senior Vice-President & CFO | 2,883 | $54.73 | $2.8B | -19.50% | +49.19% | $157.8K | -16.20% | — | Stalk |
| Mar 6, 2026 | Sell | SUPN | Frank Mottola | SVP, Chief Tech. Ops. Officer | 3,416 | $54.22 | $2.8B | -19.50% | +49.19% | $185.2K | -8.15% | — | Stalk |
| Mar 6, 2026 | Sell | SUPN | William Todd Horich | SVP, Commercial Operations | 12,332 | $54.56 | $2.8B | -19.50% | +49.19% | $672.9K | -30.71% | — | Stalk |
| Mar 6, 2026 | Sell | SUPN | Jack A. Khattar | President, CEO | 16,574 | $54.73 | $2.8B | -19.50% | +49.19% | $907.1K | -1.33% | — | Stalk |
| Feb 25, 2026 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 650 | $50.69 | $2.8B | -19.50% | +49.19% | $32.9K | -3.43% | — | Stalk |
| Feb 25, 2026 | Sell | SUPN | Jonathan Rubin | SVP, Chief Medical Officer | 675 | $50.69 | $2.8B | -19.50% | +49.19% | $34.2K | -4.42% | — | Stalk |
| Feb 25, 2026 | Sell | SUPN | Frank Mottola | SVP, Chief Tech. Ops. Officer | 977 | $50.69 | $2.8B | -19.50% | +49.19% | $49.5K | -4.66% | — | Stalk |
| Feb 25, 2026 | Sell | SUPN | Timothy C Dec | Senior Vice-President & CFO | 1,279 | $50.69 | $2.8B | -19.50% | +49.19% | $64.8K | -14.38% | — | Stalk |
| Feb 24, 2026 | Sell | SUPN | Jonathan Rubin | SVP, Chief Medical Officer | 1,643 | $30.27 | $2.8B | -19.50% | +49.19% | $49.7K | -3.71% | — | Stalk |
| Feb 24, 2026 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 1,581 | $51.04 | $2.8B | -19.50% | +49.19% | $80.7K | -2.86% | — | Stalk |
| Feb 24, 2026 | Sell | SUPN | Frank Mottola | SVP, Chief Tech. Ops. Officer | 1,641 | $51.04 | $2.8B | -19.50% | +49.19% | $83.8K | -2.85% | — | Stalk |
| Feb 24, 2026 | Sell | SUPN | Timothy C Dec | Senior Vice-President & CFO | 2,369 | $50.98 | $2.8B | -19.50% | +49.19% | $120.8K | -11.72% | — | Stalk |
| Dec 19, 2025 | Sell | SUPN | Frank Mottola | SVP, Chief Tech. Ops. Officer | 40,000 | $39.62 | $2.8B | -19.50% | +49.19% | $1.6M | +0.00% | 10b5-1 | Stalk |
| Dec 18, 2025 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 710 | $44.44 | $2.8B | -19.50% | +49.19% | $31.6K | -4.67% | — | Stalk |
| Oct 9, 2025 | Buy | SUPN | Jack A. Khattar | President, CEO | 141,150 | $36.03 | $2.8B | -19.50% | +49.19% | $5.1M | +0.58% | 10b5-1 | Stalk |
| Oct 2, 2025 | Buy | SUPN | Jack A. Khattar | President, CEO | 4,171 | $35.69 | $2.8B | -19.50% | +49.19% | $148.9K | +0.02% | 10b5-1 | Stalk |
| Oct 2, 2025 | Sell | SUPN | Jack A. Khattar | President, CEO | 15,325 | $46.21 | $2.8B | -19.50% | +49.19% | $708.2K | -0.65% | — | Stalk |
| Oct 1, 2025 | Buy | SUPN | Jack A. Khattar | President, CEO | 93,958 | $35.04 | $2.8B | -19.50% | +49.19% | $3.3M | +0.56% | 10b5-1 | Stalk |
| Sep 30, 2025 | Buy | SUPN | Jack A. Khattar | President, CEO | 20,098 | $35.11 | $2.8B | -19.50% | +49.19% | $705.6K | +0.12% | 10b5-1 | Stalk |
| Sep 29, 2025 | Buy | SUPN | Jack A. Khattar | President, CEO | 23,923 | $35.02 | $2.8B | -19.50% | +49.19% | $837.8K | +0.14% | 10b5-1 | Stalk |
| Sep 25, 2025 | Sell | SUPN | Jonathan Rubin | SVP, Chief Medical Officer | 840 | $46.21 | $2.8B | -19.50% | +49.19% | $38.8K | -7.09% | — | Stalk |
| Sep 23, 2025 | Buy | SUPN | Jack A. Khattar | President, CEO | 77,453 | $26.03 | $2.8B | -19.50% | +49.19% | $2.0M | +0.80% | 10b5-1 | Stalk |
| Sep 22, 2025 | Buy | SUPN | Jack A. Khattar | President, CEO | 43,647 | $25.92 | $2.8B | -19.50% | +49.19% | $1.1M | +0.46% | 10b5-1 | Stalk |
| Sep 12, 2025 | Sell | SUPN | Frank Mottola | SVP, Chief Tech. Ops. Officer | 10,000 | $42.63 | $2.8B | -19.50% | +49.19% | $426.4K | +0.00% | — | Stalk |
| Sep 8, 2025 | Buy | SUPN | Jack A. Khattar | President, CEO | 14,396 | $34.52 | $2.8B | -19.50% | +49.19% | $496.9K | +0.07% | 10b5-1 | Stalk |
| Sep 5, 2025 | Buy | SUPN | Jack A. Khattar | President, CEO | 128,754 | $34.24 | $2.8B | -19.50% | +49.19% | $4.4M | +0.72% | 10b5-1 | Stalk |
| Aug 27, 2025 | Buy | SUPN | Jack A. Khattar | President, CEO | 90,774 | $25.29 | $2.8B | -19.50% | +49.19% | $2.3M | +0.47% | 10b5-1 | Stalk |
| Aug 25, 2025 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 581 | $41.46 | $2.8B | -19.50% | +49.19% | $24.1K | -4.06% | — | Stalk |
| Aug 25, 2025 | Buy | SUPN | Jack A. Khattar | President, CEO | 2,611 | $25.24 | $2.8B | -19.50% | +49.19% | $65.9K | +0.03% | 10b5-1 | Stalk |
| Aug 25, 2025 | Sell | SUPN | Frank Mottola | SVP, Quality, GMP, Ops, IT | 28,000 | $28.75 | $2.8B | -19.50% | +49.19% | $804.9K | +0.00% | — | Stalk |
| Aug 22, 2025 | Buy | SUPN | Jack A. Khattar | President, CEO | 3,915 | $25.25 | $2.8B | -19.50% | +49.19% | $98.8K | +0.04% | 10b5-1 | Stalk |
| Aug 22, 2025 | Sell | SUPN | Timothy C Dec | Senior Vice-President & CFO | 11,780 | $44.49 | $2.8B | -19.50% | +49.19% | $524.1K | -90.43% | — | Stalk |
| Aug 6, 2025 | Buy | SUPN | Jack A. Khattar | President, CEO | 341,250 | $27.83 | $2.8B | -19.50% | +49.19% | $9.5M | +0.88% | 10b5-1 | Stalk |
| Mar 10, 2025 | Sell | SUPN | Timothy C Dec | Senior Vice-President & CFO | 2,017 | $32.06 | $2.8B | -19.50% | +49.19% | $64.7K | -7.60% | — | Stalk |
| Mar 10, 2025 | Sell | SUPN | Jack A. Khattar | President, CEO | 16,805 | $32.06 | $2.8B | -19.50% | +49.19% | $538.8K | -1.67% | — | Stalk |
| Mar 7, 2025 | Sell | SUPN | Frank Mottola | SVP, Quality, GMP, Ops, IT | 1,356 | $39.11 | $2.8B | -19.50% | +49.19% | $53.0K | -8.21% | — | Stalk |
| Mar 7, 2025 | Sell | SUPN | Jack A. Khattar | President, CEO | 18,581 | $39.11 | $2.8B | -19.50% | +49.19% | $726.7K | -1.87% | — | Stalk |
| Mar 5, 2025 | Sell | SUPN | Jonathan Rubin | SVP, Chief Medical Officer | 1,468 | $33.05 | $2.8B | -19.50% | +49.19% | $48.5K | -4.57% | — | Stalk |
| Mar 5, 2025 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 1,485 | $33.05 | $2.8B | -19.50% | +49.19% | $49.1K | -3.59% | — | Stalk |
| Mar 5, 2025 | Sell | SUPN | Frank Mottola | SVP, Quality, GMP, Ops, IT | 1,892 | $33.05 | $2.8B | -19.50% | +49.19% | $62.5K | -4.11% | — | Stalk |
| Mar 5, 2025 | Sell | SUPN | Timothy C Dec | Senior Vice-President & CFO | 3,193 | $33.05 | $2.8B | -19.50% | +49.19% | $105.5K | -7.96% | — | Stalk |
| Feb 26, 2025 | Sell | SUPN | Frank Mottola | SVP, Quality, GMP, Ops, IT | 2,885 | $39.48 | $2.8B | -19.50% | +49.19% | $113.9K | -8.85% | — | Stalk |
| Feb 21, 2025 | Sell | SUPN | Frank Mottola | SVP, Quality, GMP, Ops, IT | 552 | $39.15 | $2.8B | -19.50% | +49.19% | $21.6K | -3.10% | — | Stalk |
| Feb 21, 2025 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 860 | $39.15 | $2.8B | -19.50% | +49.19% | $33.7K | -4.57% | — | Stalk |
| Feb 21, 2025 | Sell | SUPN | Jonathan Rubin | SVP, Chief Medical Officer | 927 | $39.15 | $2.8B | -19.50% | +49.19% | $36.3K | -5.87% | — | Stalk |
| Feb 4, 2025 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 18,954 | $34.66 | $2.8B | -19.50% | +49.19% | $656.9K | +0.00% | — | Stalk |
| Jan 27, 2025 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 6,546 | $34.61 | $2.8B | -19.50% | +49.19% | $226.6K | +0.00% | — | Stalk |
| Dec 27, 2024 | Sell | SUPN | Jonathan Rubin | SVP, Chief Medical Officer | 1,102 | $35.59 | $2.8B | -19.50% | +49.19% | $39.2K | -8.32% | — | Stalk |
| Dec 27, 2024 | Sell | SUPN | Jack A. Khattar | President, CEO | 25,233 | $35.59 | $2.8B | -19.50% | +49.19% | $898.0K | -1.31% | — | Stalk |
| Dec 3, 2024 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 42,990 | $30.72 | $2.8B | -19.50% | +49.19% | $1.3M | +0.00% | — | Stalk |
| Nov 8, 2024 | Sell | SUPN | Jack A. Khattar | President, CEO | 250,000 | $22.71 | $2.8B | -19.50% | +49.19% | $5.7M | +0.00% | — | Stalk |
| Nov 7, 2024 | Sell | SUPN | Frank Mottola | SVP, Quality, GMP, Ops, IT | 30,000 | $23.05 | $2.8B | -19.50% | +49.19% | $691.6K | +0.00% | — | Stalk |
| Nov 7, 2024 | Sell | SUPN | Jack A. Khattar | President, CEO | 250,000 | $22.91 | $2.8B | -19.50% | +49.19% | $5.7M | +0.00% | — | Stalk |
| Sep 3, 2024 | Sell | SUPN | Jack A. Khattar | President, CEO | 10,045 | $34.90 | $2.8B | -19.50% | +49.19% | $350.6K | -1.07% | — | Stalk |
| Aug 20, 2024 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 572 | $29.57 | $2.8B | -19.50% | +49.19% | $16.9K | -5.58% | — | Stalk |
| Mar 21, 2024 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 28,982 | $30.30 | $2.8B | -19.50% | +49.19% | $878.3K | +0.00% | 10b5-1 | Stalk |
| Mar 20, 2024 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 800 | $30.30 | $2.8B | -19.50% | +49.19% | $24.2K | +0.00% | 10b5-1 | Stalk |
| Mar 19, 2024 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 24,728 | $30.31 | $2.8B | -19.50% | +49.19% | $749.4K | +0.00% | 10b5-1 | Stalk |
| Mar 13, 2024 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 124,732 | $25.68 | $2.8B | -19.50% | +49.19% | $3.2M | +0.00% | 10b5-1 | Stalk |
| Mar 12, 2024 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 7,768 | $22.99 | $2.8B | -19.50% | +49.19% | $178.5K | +0.00% | 10b5-1 | Stalk |
| Feb 28, 2024 | Sell | SUPN | Frank Mottola | SVP, Quality, GMP, Ops, IT | 460 | $27.94 | $2.8B | -19.50% | +49.19% | $12.9K | -5.58% | — | Stalk |
| Feb 28, 2024 | Sell | SUPN | Jack A. Khattar | President, CEO | 16,788 | $27.94 | $2.8B | -19.50% | +49.19% | $469.1K | -1.80% | — | Stalk |
| Feb 26, 2024 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 10,000 | $19.67 | $2.8B | -19.50% | +49.19% | $196.7K | +0.00% | 10b5-1 | Stalk |
| Feb 23, 2024 | Sell | SUPN | Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 485 | $29.06 | $2.8B | -19.50% | +49.19% | $14.1K | -0.53% | — | Stalk |
| Feb 23, 2024 | Sell | SUPN | Jonathan Rubin | SVP, Chief Medical Officer | 567 | $29.06 | $2.8B | -19.50% | +49.19% | $16.5K | -6.33% | — | Stalk |
| Feb 23, 2024 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 638 | $29.06 | $2.8B | -19.50% | +49.19% | $18.5K | -4.92% | — | Stalk |
| Feb 23, 2024 | Sell | SUPN | Frank Mottola | SVP, Quality, GMP, Ops, IT | 937 | $29.06 | $2.8B | -19.50% | +49.19% | $27.2K | -6.78% | — | Stalk |
| Feb 23, 2024 | Sell | SUPN | Timothy C Dec | Senior Vice-President & CFO | 1,314 | $29.06 | $2.8B | -19.50% | +49.19% | $38.2K | -8.21% | — | Stalk |
| Feb 22, 2024 | Sell | SUPN | Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 246 | $27.94 | $2.8B | -19.50% | +49.19% | $6.9K | -0.28% | — | Stalk |
| Feb 22, 2024 | Sell | SUPN | Jonathan Rubin | SVP, Chief Medical Officer | 303 | $27.94 | $2.8B | -19.50% | +49.19% | $8.5K | -0.85% | — | Stalk |
| Feb 22, 2024 | Sell | SUPN | Frank Mottola | SVP, Quality, GMP, Ops, IT | 335 | $27.94 | $2.8B | -19.50% | +49.19% | $9.4K | -0.86% | — | Stalk |
| Feb 22, 2024 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 372 | $27.94 | $2.8B | -19.50% | +49.19% | $10.4K | -1.07% | — | Stalk |
| Jan 10, 2024 | Sell | SUPN | Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 16,000 | $18.57 | $2.8B | -19.50% | +49.19% | $297.2K | +0.00% | 10b5-1 | Stalk |
| Dec 22, 2023 | Sell | SUPN | Jonathan Rubin | Sr. VP, Chief Medical Officer | 204 | $27.66 | $2.8B | -19.50% | +49.19% | $5.6K | -5.92% | — | Stalk |
| Dec 22, 2023 | Sell | SUPN | Jack A. Khattar | President, CEO | 11,958 | $27.66 | $2.8B | -19.50% | +49.19% | $330.8K | -1.34% | — | Stalk |
| Nov 14, 2023 | Buy | SUPN | Frank Mottola | SVP, Quality, GMP, Ops, IT | 3,110 | $15.98 | $2.8B | -19.50% | +49.19% | $49.7K | +7.68% | — | Stalk |
| Oct 13, 2023 | Sell | SUPN | Timothy C Dec | Senior Vice-President & CFO | 1,911 | $26.91 | $2.8B | -19.50% | +49.19% | $51.4K | -27.30% | — | Stalk |
| Sep 7, 2023 | Sell | SUPN | Padmanabh P. Bhatt | Sr. VP of IP, CSO | 1,182 | $32.10 | $2.8B | -19.50% | +49.19% | $37.9K | -14.16% | — | Stalk |
| Sep 7, 2023 | Sell | SUPN | Jack A. Khattar | President, CEO | 16,804 | $32.10 | $2.8B | -19.50% | +49.19% | $539.4K | -1.90% | — | Stalk |
| Aug 30, 2023 | Sell | SUPN | Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 16,200 | $28.00 | $2.8B | -19.50% | +49.19% | $453.5K | +0.00% | — | Stalk |
| Aug 25, 2023 | Sell | SUPN | Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 5,135 | $31.59 | $2.8B | -19.50% | +49.19% | $162.2K | -5.68% | — | Stalk |